ASH 2024 Insights: Ph3 EPO-PRETAR Trial - Early vs. Late Treatment With ESA in Lower-Risk Anemic MDS Patients | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Ph3 EPO-PRETAR Trial - Early vs. Late Treatment With ESA in Lower-Risk Anemic MDS Patients

By 2024 ASH Annual Meeting Insights Hub FEATURING Sophie Park

By 2024 ASH Annual Meeting Insights Hub FEATURING Sophie Park

18 views

December 18, 2024

Comments 0

Login to view comments. Click here to Login